Biological activity of palladium(II) and platinum(II) complexes of the acetone Schiff bases of S-methyl- and S-benzyldithiocarbazate and the X-ray crystal structure of the [Pd(asme)2] (asme=anionic form of the acetone Schiff base of S-methyldithiocarbazate) complex.

Palladium(II) and platinum(II) complexes of general empirical formula, [M(NS)(2)] (NS=uninegatively charged acetone Schiff bases of S-methyl- and S-benzyldithiocarbazate; M=Pt(II) and Pd(II)) have been prepared and characterized by a variety of physicochemical techniques. Based on conductance, IR and electronic spectral evidence, a square-planar structure is assigned to these complexes. The crystal and molecular structure of the [Pd(asme)(2)] complex (asme=anionic form of the acetone Schiff base of S-methyldithiocarbazate) has been determined by X-ray diffraction. The complex has a distorted cis-square planar structure with the ligands coordinated to the palladium(II) ions as uninegatively charged bidentate NS chelating agents via the azomethine nitrogen and the mercaptide sulfur atoms. The distortion from a regular square-planar geometry is attributed to the restricted bite angles of the ligands. Antimicrobial tests indicate that the Schiff bases exhibit strong activities against the pathogenic bacteria, Bacillus subtilis (mutant defective DNA repair), methicillin-resistant Staphylococcus aureus, B. subtilis (wild type) and Pseudomonas aeruginosa and the fungi, Candida albicans (CA), Candida lypotica (2075), Saccharomyces cerevisiae (20341) and Aspergillus ochraceous (398)-the activities exhibited by these compounds being greater than that of the standard antibacterial and antifungal drugs, streptomycin and nystatin, respectively. The palladium(II) and platinum(II) complexes are inactive against most of these organisms but, the microbe, Pseudomonas aeruginosa shows strong sensitivity to the platinum(II) complexes. Screening of the compounds for their cytotoxicities against T-lymphoblastic leukemia cancer cells has shown that the acetone Schiff base of S-methyldithiocarbazate (Hasme) exhibits a very weak activity, whereas the S-benzyl derivative (Hasbz) is inactive. However, the palladium(II) complexes exhibit strong cytotoxicities against this cancer; their activities being more than that of the standard anticancer drug, tamoxifen. The [Pt(asme)(2)] complex exhibits a very weak cytotoxicity, whereas [Pt(asbz)(2)] is inactive against leukemic cells.

[1]  R. Carballo,et al.  Synthesis and structural characterization of complexes of Zn(II), Cd(II) and Hg(II) halides with 2-formylpyrrole thiosemicarbazone and 2-acetylpyrrole thiosemicarbazone , 2001 .

[2]  K. Crouse,et al.  Complexes of a tridentate ONS Schiff base. Synthesis and biological properties , 2000 .

[3]  T. Rojo,et al.  Biological activity of complexes derived from pyridine-2-carbaldehyde thiosemicarbazone. Structure of. , 2001, Journal of inorganic biochemistry.

[4]  M. Ali,et al.  New nickel(II), copper(II), platinum(II) and palladium(II) complexes of a multidentate sulfur–nitrogen chelating agent , 1997 .

[5]  J. Bryan,et al.  Synthetic, spectroscopic and X-ray crystallographic structural studies on some copper(II) complexes of the 6-methylpyridine-2-carboxaldehyde Schiff base of S-methyldithiocarbazate , 1999 .

[6]  S. Livingstone,et al.  Metal chelates of dithiocarbazic acid and its derivaties. I. Complexes of dithiocarbazic acid and its S-methyl ester , 1971 .

[7]  J. Bryan,et al.  Synthesis and characterization of bis-chelated nickel(II) complexes of the methylpyruvate Schiff bases of S-alkyldithiocarbazates and the X-ray crystal structure of the [Ni(ONSMe)2] complex , 1998 .

[8]  C. Raptopoulou,et al.  Coordinating properties of 2-acetylpyridine thiosemicarbazone. Palladium(II) complexes with neutral and deprotonated ligand. X-ray structure of bromo(2-acetylpyridine thiosemicarbazonato) palladium(II) , 1994 .

[9]  R. Butcher,et al.  The preparation and characterization of bis-chelated nickel(II) complexes of the 6-methylpyridine-2-carboxaldehyde Schiff bases of S-alkyldithiocarbazates and the X-ray crystal structure of the bis {S-methyl-β-N- (6-methylpyrid-2-yl)- methylenedithiocarbazato}nickel(II) complex , 1997 .

[10]  James A. Ibers,et al.  International tables for X-ray crystallography , 1962 .

[11]  R. Butcher,et al.  Synthetic, spectroscopic, biological and X-ray crystallographic structural studies on a novel pyridine-nitrogen-bridged dimeric nickel(II) complex of a pentadentate N3S2 ligand , 2001 .

[12]  G. Sheldrick.  Phase annealing in SHELX-90: direct methods for larger structures , 1990 .

[13]  X. You,et al.  Preparation and x-ray crystal structure of deprotonated S-methyl-β-N-(pyridine N-oxide-2-ylmethylidene)dithiocarbazate pyridine nickel(II) perchlorate: [Ni(C8H8N3OS2)(C5H5N)]ClO4 , 1991 .

[14]  R. Butcher,et al.  Nickel(II), copper(II), palladium(II) and platinum(II) complexes of bidentate SN ligands derived from S-alkyldithiocarbazates and the X-ray crystal structures of the [Ni(tasbz)2] and [Cu(tasbz)2] · CHCl3 complexes , 2000 .

[15]  Ahmed A. Eltoukhy,et al.  Products and kinetics of the direct, specific transmetalation of (.mu.4-O)N4Cu(Ni(H2O))3Cl6 (N = N,N-diethylnicotinamide) by M(NS)n reagents (NS = monoanionic S-methyl isopropylidenehydrazinecarbodithioate) in nitrobenzene: a relationship between precursor stabilities and product formation rates , 1990 .

[16]  S. Livingstone,et al.  Cytotoxic action of some transition metal chelates of Schiff bases derived from S-methyldithiocarbazate. , 1978, British Journal of Cancer.

[17]  X. You,et al.  Crystal structures, spectroscopic and nonlinear optical properties of metal complexes of Schiff-base ligands containing nitrogen and sulfur donors , 1997 .

[18]  P. Sharma,et al.  Metal(II) complexes of 1-formylisoquinoline thiosemicarbazone: their preparation, characterization and antitumour activity , 1985 .

[19]  T. Oniki,et al.  The crystal structure of bis(methyl 3-benzylidenedithiocarbazato)nickel(II). , 1982 .

[20]  A. Bauer,et al.  Antibiotic susceptibility testing by a standardized single disk method. , 1966, American journal of clinical pathology.

[21]  T. Głowiak,et al.  The crystal structure of bis(S-methyl-N-isopropylidendithiocarbazate)nickel(II) , 1978 .

[22]  A. E. Liberta,et al.  The chemical and antifungal properties of the copper(II) complexes of 2-acetylpyrazine4N-methyl-,4N-dimethyl-, and 3-hexamethyleneiminylthiosemicarbazone , 1990 .

[23]  A. E. Liberta,et al.  Metal ion complexes of 2-acetylpyridine 3-(4-methyl)piperazinyl-thiosemicarbazone , 1992 .

[24]  S. Livingstone,et al.  Metal complexes of sulphur-nitrogen chelating agents , 1974 .

[25]  R. Bose,et al.  Transition metal complexes of furfural and benzil schiff bases derived from S-benzyldithiocarbazate , 1984 .

[26]  M. Lockwood,et al.  Spectral nature, antifungal activity and molecular structure of metal complexes of acetylpyrazine 4N-substituted thiosemicarbazones , 1993 .

[27]  T. Mosmann.  Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. , 1983, Journal of immunological methods.

[28]  Stuart A. Rice,et al.  Inorganic Electronic Spectroscopy , 1968 .